Clinical Trial

Auto Stem Cell Transplant for Lymphoma Patients

Name: Auto Stem Cell Transplant for Lymphoma Patients — clinical trial record (NCT03125642)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a phase II study of autologous transplant for patients with Hodgkin (HL) and non-Hodgkin lymphomas (NHL) including those who are HIV positive.

Protocol Amendment History 12 amendments

This ClinicalTrials.gov record has been amended 12 times since 2017-04-19; most recent amendment 2025-10-31.

Status change: Not Yet Recruiting → Recruiting 2017-04-24

Trial Details

NCT Number	NCT03125642
Lead Sponsor	Masonic Cancer Center, University of Minnesota
Conditions	Non-Hodgkin Lymphoma, Hodgkin Lymphoma
Enrollment	150 participants
Start Date	2017-04-20
Primary Completion	2026-09-30 (estimated)
Study Completion	2027-04-30 (estimated)
Updated on ClinicalTrials.gov	2025-11-04